MACTEC, Inc. v. Gorelick

427 F.3d 821, 77 U.S.P.Q. 2d (BNA) 1097, 2005 U.S. App. LEXIS 23135, 2005 WL 2767135
CourtCourt of Appeals for the Tenth Circuit
DecidedOctober 26, 2005
Docket03-1290, 03-1378
StatusPublished
Cited by138 cases

This text of 427 F.3d 821 (MACTEC, Inc. v. Gorelick) is published on Counsel Stack Legal Research, covering Court of Appeals for the Tenth Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
MACTEC, Inc. v. Gorelick, 427 F.3d 821, 77 U.S.P.Q. 2d (BNA) 1097, 2005 U.S. App. LEXIS 23135, 2005 WL 2767135 (10th Cir. 2005).

Opinion

EBEL, Circuit Judge.

This case involves a contract dispute over payment of royalties for a patented invention. The parties to the contract differed as to the meaning of a contractual term and, pursuant to the agreement, arbitrated their dispute. After a hearing, the arbitrator found for Defendant Gorelick and awarded $4.5 million. Plaintiff MAC-TEC, Inc. filed an application in district court to vacate the arbitration award pursuant to the Federal Arbitration Act, 9 U.S.C. § 10 (2000) (“FAA”). Along with that application, MACTEC filed a declaratory judgment action on the grounds that the arbitrator’s interpretation of the disputed contractual term constituted illegal patent misuse. In separate orders, the district court denied the application to vacate and dismissed the declaratory judgment action. MACTEC appealed both de *824 cisions to this court, and we consolidated the appeals for a hearing before a single panel.

As a matter of first impression in this circuit, we conclude that a non-appealability clause in an arbitration agreement that forecloses judicial review of an arbitration award beyond the district court level is enforceable. Due to the presence of such a clause in the instant arbitration agreement, we hold that we lack jurisdiction over MACTEC’s appeal from the district court’s denial of the application to vacate the arbitration award and DISMISS the case.

Regarding MACTEC’s appeal from the dismissal of its declaratory judgment action, we conclude that the doctrine of res judicata bars the suit and we AFFIRM the district court’s dismissal.

BACKGROUND

I. Factual history.

A. Development and assignment of the NoVOCs technology

While a professor at Stanford University, Defendant-Appellee Steven Gorelick (“Gorelick”) and one of his colleagues, Haim Gvritzman (“Gvritzman”), developed a new method for removing volatile organic contaminants from groundwater (“the NoVOCs technology”). What was unique about this technology is that it was designed to remove the contaminants in situ, or while the water was still underground, by using processes known as vapor stripping and gas pumping.

In 1991, Gorelick and Gvritzman assigned “any right, title, and interest,” in the NoVOCs technology to Stanford, including the right to seek a patent. In return for their assignment, Gorelick and Grivtzman each received a one-sixth share of net royalty income, with the remaining two-thirds royalty going to the university. Stanford subsequently applied for, and received, a patent for the NoVOCs technology and has owned that patent ever since.

In 1992, Gorelick formed a company called NoVOCs, Inc., (“NoVOCs”) with the intention of developing profitable wells that used the NoVOCs technology. To that end, NoVOCs obtained an exclusive license from Stanford to use the patented technology in exchange for a series of annual royalties. Gorelick was the sole shareholder and manager of NoVOCs.

In 1994, Gorelick sold all of his shares in NoVOCs to a company called EG & G, pursuant to a stock purchase agreement. In return for the stock, EG & G agreed to pay Gorelick an up-front payment of just under $3.3 million. In addition, EG & G agreed to give Gorelick installment payments of (1) twenty-five percent of future revenue derived from licenses or sub-licenses of the NoVOCs technology; and (2) $3000 for each well EG & G drilled using the NoVOCs technology. By acquiring all of Gorelick’s stock, EG & G became the exclusive license holder of Stanford’s patent and thereby assumed NoVOCs’ obligations to pay royalties to the university. The stock purchase agreement provided that all disputes arising under the agreement would be governed by California law and would be subject to arbitration. Two aspects of the stock purchase agreement are particularly relevant to this appeal: First, the agreement specifically excluded from the scope of arbitrable issues any disputes relating to patent invalidity or infringement. Second, the agreement provided that any judgment upon the award rendered by the arbitrator would be final and nonappealable.

B. Entrance of MACTEC and subsequent re-negotiations

In 1997, EG & G agreed to sell certain of its assets to Plaintiff-Appellant MAC- *825 TEC, Inc. (“MACTEC”) including its stock in NoVOCs (and, by implication, NoVOCs’ license to Stanford’s patent over the No-VOCs technology). In a separate written instrument, MACTEC became the successor-in-interest to the stock purchase agreement between EG & G and Gorelick, expressly assuming all of EG & G’s payment obligations to Stanford and Gorelick.

In 1998, MACTEC, through one of its LLC subsidiaries, began using a different method of in situ groundwater treatment in some of its wells, known as “UBV” technology. 1 Because the NoVOCs and UBV technologies overlapped, MACTEC was unsure as to whether the use of the UBV technology would trigger the $3000 per-well royalty obligation to Gorelick it had assumed in the stock purchase agreement. As a result, MACTEC approached Gorelick with the intention of re-negotiating the royalty payments.

The parties eventually agreed in writing to reduce Gorelick’s royalty payment to $1500 for each “remediation well” that was installed by the LLC. For remediation wells not installed by the LLC, but rather by another entity under the MACTEC umbrella, Gorelick would continue to receive his original $3000 payment. The term “remediation well” is defined in the document as “any hole that (i) has been dug, drilled, or otherwise installed, or (ii) which existed and has been converted in use, and that is employed or intended for the partial or complete removal treatment of subsurface contaminants.” Nowhere in the written agreement did MACTEC condition Gorelick’s payment on a given well’s use of NoVOCs or UBV technology.

C. Royalty payment dispute

For the next two years, Gorelick received occasional payments from MAC-TEC, ranging from $1500 to $4500. Gorelick received the final payment on November 15, 2000. One month later, Gorelick learned from Stanford that MACTEC had canceled its licensing agreement for the NoVOCs technology. Gorelick then called executives at MAC-TEC who stated that since their relationship with Stanford had terminated, they no longer had royalty obligations to Gorelick.

Gorelick responded that his agreement with MACTEC was a separate legal obligation which he expected MACTEC to honor. In addition, Gorelick asked MAC-TEC for specific information regarding remediation wells for which he was entitled to receive payment because he felt that there had been inadequate reporting throughout the whole process. MACTEC did not provide the requested information, and instead alleged that the NoVOCs technology had caused the company as much as $3 million in damages.

II. Procedural history.

On August 6, 2001, Gorelick filed a demand for arbitration to recover payments under the stock purchase agreement.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
427 F.3d 821, 77 U.S.P.Q. 2d (BNA) 1097, 2005 U.S. App. LEXIS 23135, 2005 WL 2767135, Counsel Stack Legal Research, https://law.counselstack.com/opinion/mactec-inc-v-gorelick-ca10-2005.